reptile
发表于 2025-3-25 03:32:00
Exploring Marine Biodiversity as Alternative Resources for Treatment of Human Parasitic Diseases,recognized with a variety of substances from the classes predominately from invertebrates including tunicates, sponges, bryozoans, molluscs marine cyanobacteria and bacteria, which targets many diseases including the three protozoan diseases mentioned above. As the diseases progress and develop resi
ascend
发表于 2025-3-25 11:00:25
http://reply.papertrans.cn/67/6619/661883/661883_22.png
MILL
发表于 2025-3-25 13:24:40
http://reply.papertrans.cn/67/6619/661883/661883_23.png
浓缩
发表于 2025-3-25 17:59:59
http://reply.papertrans.cn/67/6619/661883/661883_24.png
FOIL
发表于 2025-3-25 22:40:29
http://reply.papertrans.cn/67/6619/661883/661883_25.png
Expostulate
发表于 2025-3-26 03:07:00
http://reply.papertrans.cn/67/6619/661883/661883_26.png
考博
发表于 2025-3-26 05:56:33
Strategies and Challenges for Developing Plant-Based Therapeutics Against Protozoans,ese bioactive compounds present in the crude extracts and essential oils of medicinal plants are quintessential components for strategies to develop plant-based therapeutics against Protozoans. This chapter highlights the potential of plant-based compounds as powerful anti-protozoan drugs and future
致命
发表于 2025-3-26 11:58:07
http://reply.papertrans.cn/67/6619/661883/661883_28.png
hegemony
发表于 2025-3-26 13:55:30
Target-Based Rational Improvement Strategies and Pitfalls in , Drug Discovery,o potential theranostics against . due to the clinical and acquired resistance. Thus, we must find new a weapon or strategies, such as drug repurposing by using drugs already available for other diseases. Several antileishmanial drugs are available for treating leishmaniasis, including repurposed dr
intimate
发表于 2025-3-26 18:57:55
http://reply.papertrans.cn/67/6619/661883/661883_30.png